drugset / Trial / NCT00400491

Vitamin D Supplementation to Patients With Type 2 Diabetes

NCT00400491

Phase 2 Completed 40 enrolled University of Tromso
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to evaluate if supplementation with vitamin D in a dose of 40.000 IU per week will result in improved metabolic control in patients with type 2 diabetes.

Timeline

Start
2006-06
Primary completion
2007-08
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 20000 iu